- Home
- CURR vs WHWK Comparison
CURR vs WHWK Comparison
Compare CURR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURR | WHWK |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.6M | 95.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CURR | WHWK |
|---|---|---|
| Price | $1.46 | $2.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 224.6K | 108.0K |
| Earning Date | 11-01-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,227,053.00 | $14,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $1.39 |
| 52 Week High | $4.68 | $3.77 |
Technical Indicators
Market Signals| Indicator | CURR | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 35.89 | 52.12 |
| Support Level | $1.51 | $2.60 |
| Resistance Level | $1.64 | $2.83 |
| Average True Range (ATR) | 0.14 | 0.19 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 16.22 | 41.47 |
Price Performance
Historical ComparisonAbout CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.